I'm looking
for help...
Aidpage is free!
   

Free downloads: GrantGate®  Federal Money Retriever®

MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AWARD WITH EMPHASIS ON
THE APPLICATION OF GENOMIC OR PROTEOMIC TECHNOLOGIES (K23)

Published on AidPage by IDILOGIC on Jun 24, 2005
Administered by:

Department of Health and Human Services, National Institutes of Health, National Institutes of Health
(see all US Federal Agencies)

Explore all postings for this grant program:
Applications Due:

Oct 20, 2005
October 20, 2003; October 20, 2004; and October 20, 2005

total funding: Not Available
max award: none
min award: none
cost sharing, matching: No
number of awards: Not Available
type of funding: Grant
Description:

The purpose of the Mentored Patient-Oriented Research Career Development Award
(K23) is to support the career development of clinicians who intend to engage in
patient-oriented research that involves the application of the knowledge, tools,
technologies and approaches of genomics and proteomics to the study of diseases
in an effort to develop effective therapeutic interventions. This award will
provide support for three to five years of supervised study and research for
clinically trained professionals who plan to become independent, productive
clinical investigators focusing on patient-oriented research.

This K23 award has several important features: (1) it requires an integrated
clinical-laboratory research project that directly involves patients affected by
the disease being studied so that awardees can develop skills in both clinical
research and basic science, i.e. bench-to-bedside research; (2) it emphasizes
career development and a research program that focuses on developing effective
therapeutic interventions; projects that involve pre-therapeutic research will
also be considered if the applicant can make a strong case that the knowledge
gained from the study will provide a clear pathway toward the development of
therapeutic interventions; and (3) it requires significant utilization of
genomic and proteomic tools and technologies in the research project.

NHGRI: This initiative is consistent with the NHGRI's new vision for the future
of genomics research (http://www.genome.gov/11006873) which includes translating
the information and resources generated by the Human Genome Project into medical
value and is responsive to the recommendations of the NIH Director's panel on
Clinical Research (http://www.nih.gov/news/crp/97report/) and the Institute of
Medicine's Committee on Addressing Career paths for Clinical Research
(http://www.nap.edu/books/0309048907/html/).

ORD: Under the Rare Diseases Act of 2002, the office has a legislative mandate
to support training in clinical research in rare diseases.

NIDA: The institute is interested in the application of genomic and proteomic
tools and technologies in pursuit of therapeutic interventions in drug addiction
and drug abuse.

The NHGRI's Division of Intramural Research in Bethesda, MD, has a companion
program, Physician Scientist Development Program, for clinicians who wish to
conduct their research at the National Institutes of Health. To learn more
about this program, please visit this website:
http://www.nhgri.nih.gov/Intramural_research/PSDP/index.html.

Individuals with a clinical degree who are interested in further career
development in biomedical research that is not patient-oriented, should refer to
the NIH-wide Mentored Clinical Scientist Career Development (K08) Award (see
http://grants.nih.gov/training/careerdevelopmentawards.htm on the NIH website
for details). Individuals who are interested in patient-oriented research and
wish to 1) study the mechanisms of human disease, 2) conduct clinical trials,
3) develop new technologies, or 4) develop therapeutic interventions that do
not use genomic or proteomic technologies should refer to the Mentored Patient-
Oriented Research Career Development (K23) Award (see
http://grants.nih.gov/grants/guide/PA-files/PA-00-004.html).

Who can apply:

Anyone/General Public
City Or Township Governments
County Governments
Federally Recognized Indian Tribal Governments
Independent School Districts
Individual/Family
Minority Group
Native American Organization
Non-Government - General
Nonprofits Having A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Nonprofits That Do Not Have A 501(C)(3) Status With The IRS, Other Than Institutions Of Higher Education
Other Private Institution/Organization
Private Institutions Of Higher Education
Private Nonprofit Institution/Organization (Includes Institutions Of Higher Education, Hospitals)
Profit Organization
Public And State Controlled Institutions Of Higher Education
Public Housing Authorities/Indian Housing Authorities
Small Business (Less Than 500 Employees
Special District Governments
State (Includes District Of Columbia; Includes Institutions Of Higher Education And Hospitals)
U.S. Territories And Possessions (Includes Institutions Of Higher Education, Hospitals)

Eligible functional categories:
Funding Sources:

Drug Abuse Research Programs
Human Genome Research

More Information:

http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-03-006.html

If you have problems accessing the full announcement, please contact: Webmaster, NIH

Address Info:

Office of Extramural Programs 6705 Rockledge Drive Bethesda, MD 20892-7963

SPONSORED LINKS
Free downloads: GrantGate®  Federal Money Retriever®
Apply for grants and loans! Click here to start